Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cytori’s Stem Cell Therapy for Burns Wins U.S. Contract
Bloomberg
Friday, September 28, 2012 - 10:45am
tags:
stem cells, Cytori, burns
Teva Pharma acquires rights to Huntexil for $26M
Yahoo/AP
Friday, September 28, 2012 - 10:35am
tags:
Teva Pharmaceuticals, Huntexil, Huntington's disease, Neurosearch
Glaxo, Cipla Seen as Biggest Losers as India Sets Prices
Bloomberg
Friday, September 28, 2012 - 10:24am
tags:
GSK, Cipla, India
A.P. Pharma Resubmits New Drug Application for APF530, a Product Candidate for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Yahoo
Friday, September 28, 2012 - 10:22am
tags:
AP Pharma, APF530, chemotherapy-induced nausea and vomiting
VEN-307 is Ideal for a Small Company to Launch, says Ventrus CEO
Yahoo/Reuters
Friday, September 28, 2012 - 10:20am
tags:
Ventrus, VEN-307, anal fissures
5 Low Risk, High Reward Biotech Stocks
Motley Fool
Friday, September 28, 2012 - 10:19am
tags:
Arena Pharmaceuticals, Aeterna Zentaris, Incyte, Jazz Pharmaceuticals, Astex
[video] The Next Big Thing in Biotech: Hepatitis Drugs
TheStreet.com
Friday, September 28, 2012 - 10:18am
tags:
hepatitis C, Abbott Labs, Gilead Sciences, JNJ, Merck, Vertex Pharmaceuticals, Idenix, Achillion
How Well Does Pharma Disclose Political Spending?
Pharmalot
Friday, September 28, 2012 - 8:53am
tags:
political spending, pharma industry, Merck
Abbott misstated credentials of spinoff CEO Gonzalez
Yahoo/Reuters
Thursday, September 27, 2012 - 6:54pm
tags:
Abbott Labs, AbbVie, Richard Gonzalez
Why WuXi PharmaTech's Earnings May Be Less Than Awesome
Motley Fool
Thursday, September 27, 2012 - 6:53pm
tags:
earnings, WuXi PharmaTech
10 Reasons To Buy Ampio Pharmaceuticals
Seeking Alpha
Thursday, September 27, 2012 - 6:50pm
tags:
Ampio Pharmaceuticals
Science advisors lay out ambitious plan to double FDA approval rates
Fierce Biotech
Thursday, September 27, 2012 - 11:37am
tags:
FDA, drug approvals
Pfizer, Merck Ink Deals In China To Make Up For Shrinking Revenue
Seeking Alpha
Thursday, September 27, 2012 - 11:34am
tags:
Pfizer, Merck, China, GSK, JNJ, Zhejiang Hisun Pharma, Novartis
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bloomberg
Thursday, September 27, 2012 - 11:26am
tags:
colorectal cancer, Bayer, ONYX Pharmaceuticals, FDA, regorafenib
Depomed sues FDA over 'additional hurdles' to orphan exclusivity
Fierce Pharma
Thursday, September 27, 2012 - 11:24am
tags:
FDA, Depomed, Gralise
As AstraZeneca's new CEO prepares to step in, calls for M&A intensify
Fierce Pharma
Thursday, September 27, 2012 - 11:24am
tags:
AstraZeneca, M&A, Pascal Soriot
ACLU Asks Supreme Court To Review Gene Patents
Pharmalot
Thursday, September 27, 2012 - 11:22am
tags:
genes, patents, Mylan, ACLU
Reckitt's Decision Opens The Door For Titan Pharma And BioDelivery Sciences
Seeking Alpha
Thursday, September 27, 2012 - 11:14am
tags:
BioDelivery Sciences, Reckitt Benckiser, Titan Pharmaceuticals, Suboxone, opioid addiction
Forest Labs files for approval of depression drug
Yahoo/AP
Thursday, September 27, 2012 - 11:12am
tags:
antidepressants, Forest Labs, levomilnacipran
Hemispherx's Ampligen Rehash Unlikely to Impress FDA
TheStreet.com
Thursday, September 27, 2012 - 10:53am
tags:
Hemispherx, Ampligen, FDA, chronic fatigue syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.